{"id":"W4405128969","doi":"10.1038/s41391-024-00924-x","title":"Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Abiraterone acetate; Medicine; Enzalutamide; Olaparib; Prostate cancer; Oncology; Internal medicine; Confidence interval; Hazard ratio; Urology; Cancer; Androgen deprivation therapy; Poly ADP ribose polymerase; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0005894405,0.001236961,0.002055107,0.000561694,0.0007968795,0.001190924,0.0002509063,0.0001768097,0.0001424755],"category_scores_gemma":[0.0001264902,0.0009880554,0.000278005,0.0009186866,0.0009047976,0.0009912759,0.0002307199,0.0006693546,0.00002113629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001465844,"about_ca_system_score_gemma":0.003585878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002124214,"about_ca_topic_score_gemma":0.001506105,"domain_scores_codex":[0.993615,0.0002449493,0.001417699,0.001887682,0.001032409,0.001802266],"domain_scores_gemma":[0.9966286,0.0006610557,0.0004294829,0.0005744679,0.000515023,0.001191355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2882189,0.002233097,0.04186059,0.09558862,0.01931206,0.003771789,0.1225066,0.01074434,0.04084943,0.001822754,0.01791258,0.3551792],"study_design_scores_gemma":[0.3731078,0.03020663,0.1155218,0.03058877,0.04600435,0.0007226806,0.04135608,0.2081056,0.0558524,0.01359454,0.07070676,0.01423256],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8342215,0.142197,0.0002033857,0.003701783,0.001162362,0.00894963,0.008929802,0.0005241203,0.0001105034],"genre_scores_gemma":[0.9594755,0.02218102,0.001103512,0.0003307716,0.0002653363,0.008428306,0.002188937,0.000297266,0.005729329],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3409467,"threshold_uncertainty_score":0.9998459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06014608473707125,"score_gpt":0.3616965064831839,"score_spread":0.3015504217461127,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}